Director, U.S. Asset Lead, Oncology (GI Tumor & GIST) - Philadelphia, PA

Business Introduction:

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centered on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.
Our diverse portfolio consists of vaccines, specialty medicines, and general medicines.
Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.

Position Summary:

The Director, U.S. Asset Lead is responsible for representing the U.S. commercial perspective across the lifecycle of a GI tumor asset and an additional oncology asset, ensuring development, commercialization strategy, and launch planning are optimized for the U.S. market. This role serves as the primary U.S. commercial leader interfacing with the global asset team, providing strategic guidance on target product profile (TPP), market positioning, clinical development prioritization, and commercial readiness to maximize asset value.

The Director will work cross-functionally with Global Development, Medical Affairs, Market Access, Commercial Strategy, Regulatory, Forecasting, and Business Insights to shape the development path and commercialization strategy. The role requires deep expertise in U.S. oncology market dynamics, competitive intelligence, payer landscape, and launch excellence, ensuring the U.S. perspective informs global decisions from early development through launch and lifecycle management.

Key Responsibilities:

U.S. Asset Strategy Leadership:

• Serve as the U.S. commercial lead for assigned oncology assets, ensuring the U.S. perspective is embedded in development and commercialization decisions.

• Provide strategic input into TPP assumptions to ensure alignment with U.S. market needs.

• Shape U.S. positioning strategy, value proposition, and differentiation relative to current and emerging competitors.

• Translate U.S. market insights into actionable strategy for global development teams.

Clinical Development & Indication Strategy:

• Partner with Global Development and Medical teams to ensure clinical programs support future U.S. commercial success.

• Provide commercial input into:

  • Indication prioritization

  • Endpoint selection

  • Comparator strategy

  • Trial design considerations

• Identify opportunities to optimize label potential and market access positioning.

U.S. Market Intelligence & Competitive Strategy:

• Lead or contribute to U.S. market landscape assessments, including:

  • Disease epidemiology

  • Treatment paradigms

  • Competitive intelligence

  • Emerging modalities

• Monitor evolving competitive pipelines across GI, GU, and related tumor types, translating insights into strategic implications.

• Partner with Business Insights and Analytics to synthesize U.S. market signals into global decision making.

Forecasting & Business Case Development:

• Collaborate with forecasting teams to develop robust U.S. revenue forecasts and scenario planning.

• Lead assessment of commercial opportunity, pricing potential, and market uptake dynamics.

• Provide strategic input into investment decisions and lifecycle planning.

Commercial Launch Excellence:

• Lead early U.S. launch readiness in partnership with global and U.S. commercial teams.

• Define core U.S. launch strategy, including:

  • Customer segmentation

  • Positioning and messaging

  • Access strategy

  • Commercial model considerations

• Ensure alignment across Sales, Marketing, Market Access, and Medical Affairs to enable successful launch execution.

Cross-Functional Leadership:

• Serve as a key integrator across:

  • Global Asset Teams

  • U.S. Commercial Leadership

  • Medical Affairs

  • Market Access

  • Forecasting

  • Business Development

• Drive alignment across stakeholders to ensure timely and strategic decision making.

External Engagement & Market Shaping:

• Engage with key opinion leaders (KOLs), advocacy groups, and clinical experts to inform development and commercial strategy.

• Represent the company at major oncology congresses to gather insights and assess the competitive landscape.

• Support efforts to shape treatment paradigms and standard-of-care evolution in relevant tumor types.

Leadership Competencies:

• Strategic thinking and ability to translate insights into actionable strategy

• Enterprise leadership across complex global matrix organizations

• Strong commercial acumen in oncology markets

• Influencing without authority

• Data-driven decision making

• Ability to balance long-term asset value creation with near-term development priorities

Why You?

Basic Qualifications:

We are looking for professionals with these required skills to achieve our goals:

• Bachelor’s degree in business, life sciences, healthcare, or related field.

• 10+ years of experience in the biopharmaceutical industry, with significant experience in oncology.

• Experience supporting late-stage development, launch planning, or commercialization of oncology therapies.

• Location: Must be able to work onsite - Monday through Friday.

Preferred Qualifications:

If you have the following characteristics, it would be a plus:

• Proven ability to influence global cross-functional teams in a matrix environment.

• Demonstrated expertise in U.S. oncology market dynamics, particularly GI (and GIST) cancers

• Marketing background

• Pipeline experience

• Sales experience

Impact of the Role:

The Director, U.S. Asset Lead plays a critical role in ensuring assigned oncology assets are developed and positioned for maximum success in the U.S. market. By integrating U.S. market insights into global strategy, this role helps ensure development decisions translate into strong clinical adoption, competitive differentiation, and commercial success at launch.

#LI-GSK

#GSKCommercial

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

If you require an accommodation or other assistance to apply for a job at GSK, please contact the appropriate Recruitment Staff by emailing us at - usrecruitment.adjustments@gsk.com

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.

Important notice to Employment businesses/ Agencies

GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.

Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit the Centers for Medicare and Medicaid Services (CMS) website at https://openpaymentsdata.cms.gov/